Continuation and maintenance therapy in depression.

This paper reviews longer term treatment for unipolar depression. Antidepressant continuation for prevention of early relapse has been routine for many years. Recent evidence supports a longer period of 9 months to 1 year after remission. Antidepressants are also effective in maintenance treatment for recurrent depression, and are indicated where there is clear risk of further episodes. Antidepressant withdrawal after continuation and maintenance should always be gradual, over a minimum of 3 months and longer after longer maintenance periods, to avoid withdrawal symptoms or rebound relapse. Trials of interpersonal therapy in the prevention of recurrence show some benefit, but effects are weaker than those of drug and additional benefit in combination is limited. There is better evidence for effects of cognitive therapy in preventing relapse and an emerging indication for its addition to antidepressants, particularly where residual symptoms are present.

[1]  R Ramana,et al.  Remission and relapse in major depression: a two-year prospective follow-up study , 1995, Psychological Medicine.

[2]  J. Teasdale,et al.  Prevention of relapse in residual depression by cognitive therapy: a controlled trial. , 1999, Archives of general psychiatry.

[3]  D J Kupfer,et al.  Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination. , 1984, Archives of general psychiatry.

[4]  D J Kupfer,et al.  Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years. , 1999, JAMA.

[5]  R. DeRubeis,et al.  Differential relapse following cognitive therapy and pharmacotherapy for depression. , 1992, Archives of general psychiatry.

[6]  P. Lavori,et al.  Maintenance strategies for unipolar depression: an observational study of levels of treatment and recurrence. , 1998, Journal of affective disorders.

[7]  J. Teasdale,et al.  Levels of Expressed Emotion and Relapse in Depressed Patients , 1986, British Journal of Psychiatry.

[8]  F. Quitkin,et al.  Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: a prospective, placebo-controlled comparison. , 1982, Archives of general psychiatry.

[9]  D. Kupfer,et al.  Continuation drug therapy for major depressive episodes: how long should it be maintained? , 1986, The American journal of psychiatry.

[10]  G. Dunbar,et al.  Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression , 1993, International clinical psychopharmacology.

[11]  M. Sa,et al.  Fluvoxamine prevents recurrence of depression: results of a long-term, double-blind, placebo-controlled study. , 1998 .

[12]  D J Kupfer,et al.  Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. , 1991, Archives of general psychiatry.

[13]  G. Klerman,et al.  Treatment effects on the social adjustment of depressed patients. , 1974, Archives of general psychiatry.

[14]  M. Shepherd,et al.  An evaluation of continuation therapy with tricyclic antidepressants in depressive illness , 1973, Psychological Medicine.

[15]  G. Fava,et al.  Prevention of recurrent depression with cognitive behavioral therapy: preliminary findings. , 1998, Archives of general psychiatry.

[16]  T. Cooper,et al.  A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients. , 1989, Archives of general psychiatry.

[17]  J. Markowitz,et al.  Maintenance therapy for chronic depression. A controlled clinical trial of desipramine. , 1996, Archives of general psychiatry.

[18]  E. Paykel,et al.  Amitriptyline, Weight Gain and Carbohydrate Craving: A Side Effect , 1973, British Journal of Psychiatry.

[19]  J. Teasdale,et al.  Effects of cognitive therapy on psychological symptoms and social functioning in residual depression , 2000, British Journal of Psychiatry.

[20]  J. Fleiss,et al.  Response to maintenance therapy in bipolar illness. Effect of index episode. , 1989, Archives of general psychiatry.

[21]  S. Montgomery,et al.  The Prophylactic Efficacy of Fluoxetine in Unipolar Depression , 1988, British Journal of Psychiatry.

[22]  R Ramana,et al.  Residual symptoms after partial remission: an important outcome in depression , 1995, Psychological Medicine.

[23]  K. Rickels,et al.  Maintenance therapy with amitriptyline: a controlled trial. , 1980, The American journal of psychiatry.

[24]  K. Björk.  The efficacy of zimeldine in preventing depressive episodes in recurrent major depressive disorders — a double‐blind placebo‐controlled study , 1983, Acta psychiatrica Scandinavica. Supplementum.

[25]  M. Shepherd,et al.  Continuation therapy with lithium and amitriptyline in unipolar depressive illness: a randomized, double-blind, controlled trial , 1984, Psychological Medicine.

[26]  A. Amdisen,et al.  Prophylactic lithium: double blind discontinuation in manic-depressive and recurrent-depressive disorders. , 1970, Lancet.

[27]  A. Simons,et al.  Cognitive therapy and pharmacotherapy for depression. Sustained improvement over one year. , 1986, Archives of general psychiatry.

[28]  J. Rabkin,et al.  Phenelzine for chronic depression: a study of continuation treatment. , 1986, The Journal of clinical psychiatry.

[29]  J. Amsterdam,et al.  Optimal length of continuation therapy in depression: a prospective assessment during long-term fluoxetine treatment. , 1998, The American journal of psychiatry.

[30]  R. L. Bird,et al.  Imipramine with electrical treatment in depression--a controlled trial. , 1962, The Journal of mental science.

[31]  S. Montgomery,et al.  Continuation Therapy with Amitriptyline in Depression , 1978, British Journal of Psychiatry.

[32]  E. Smeraldi,et al.  A 24-month follow-up study of unipolar subjects: a comparison between lithium and fluvoxamine. , 1994, Journal of affective disorders.

[33]  F. Quitkin,et al.  Prophylactic lithium carbonate with and without imipramine for bipolar 1 patients. A double-blind study. , 1981, Archives of general psychiatry.

[34]  R. Fieve,et al.  Lithium prophylaxis of depression in bipolar I, bipolar II, and unipolar patients. , 1976, The American journal of psychiatry.

[35]  P W Lavori,et al.  Predictors of relapse in major depressive disorder. , 1983, JAMA.

[36]  S. Montgomery,et al.  A 24‐week study of 20 mg citalopram, 40 mg citalopram, and placebo in the prevention of relapse of major depression , 1993, International clinical psychopharmacology.

[37]  D. Kupfer,et al.  Comparison of full-dose versus half-dose pharmacotherapy in the maintenance treatment of recurrent depression. , 1993, Journal of affective disorders.

[38]  G. Fava,et al.  Six-year outcome for cognitive behavioral treatment of residual symptoms in major depression. , 1998, The American journal of psychiatry.

[39]  R. Murray,et al.  The Long-Term Outcome of Maudsley Depressives , 1988, British Journal of Psychiatry.

[40]  G. Klerman,et al.  Treatment of depression by drugs and psychotherapy. , 1974, The American journal of psychiatry.

[41]  I. Glick,et al.  Effectiveness in Psychiatric Care , 1994, British Journal of Psychiatry.

[42]  J. Greden,et al.  Antidepressant withdrawal phenomena. , 1984, Biological psychiatry.

[43]  J. Leff,et al.  The measurement of expressed emotion in the families of psychiatric patients. , 1976, The British journal of social and clinical psychology.

[44]  M. Shea,et al.  Course of depressive symptoms over follow-up. Findings from the National Institute of Mental Health Treatment of Depression Collaborative Research Program. , 1992, Archives of general psychiatry.

[45]  A. Coppen,et al.  Mianserin and Lithium in the Prophylaxis of Depression , 1978, British Journal of Psychiatry.

[46]  A. Coppen,et al.  Prophylactic lithium in affective disorders. Controlled trial. , 1971, Lancet.

[47]  G. Andrews,et al.  The Long-Term Outcome of Depressive Illness , 1988, British Journal of Psychiatry.

[48]  V. Caillard,et al.  Sertraline in the Prevention of Depression , 1992, British Journal of Psychiatry.

[49]  T. Wetterling,et al.  Comparative efficacy of lithium and amitriptyline in the maintenance treatment of recurrent unipolar depression: a randomised study. , 1996, Journal of affective disorders.

[50]  M. Trivedi,et al.  Double-blind, placebo-substitution study of nefazodone in the prevention of relapse during continuation treatment of outpatients with major depression. , 1999, International clinical psychopharmacology.

[51]  D. Melzer,et al.  Medication received by patients with depression following the acute episode: adequacy and relation to outcome , 1999, British Journal of Psychiatry.

[52]  P. Lavori,et al.  Recovery in major depressive disorder: analysis with the life table and regression models. , 1982, Archives of general psychiatry.

[53]  G. Keitner,et al.  Cognitive-behavioral treatment of depressed inpatients: six- and twelve-month follow-up. , 1989, The American journal of psychiatry.

[54]  M. Mesbah,et al.  Prevention of recurrent depressive episodes with milnacipran: consequences on quality of life. , 2000, Journal of affective disorders.

[55]  C. Barkley,et al.  Future Imperfect: the Long-Term Outcome of Depression , 1994, British Journal of Psychiatry.

[56]  A. Coppen,et al.  Lithium Continuation Therapy Following Electroconvulsive Therapy , 1981, British Journal of Psychiatry.

[57]  J. Stewart,et al.  Prophylactic efficacy of phenelzine and imipramine in chronic atypical depression: likelihood of recurrence on discontinuation after 6 months' remission. , 1997, The American journal of psychiatry.

[58]  S. Montgomery,et al.  A Double-Blind Comparison of Lithium Carbonate and Maprotiline in the Prophylaxis of the Affective Disorders , 1976, British Journal of Psychiatry.

[59]  R G Priest,et al.  Recognition and management of depression in general practice: consensus statement. , 1992, BMJ.

[60]  J. Lépine,et al.  Citalopram in doses of 20–60 mg is effective in depression relapse prevention: a placebo‐controlled 6 month study , 1995, International clinical psychopharmacology.

[61]  A. Young,et al.  Serotonin reuptake inhibitor discontinuation syndrome: a hypothetical definition. Discontinuation Consensus panel. , 1997, The Journal of clinical psychiatry.

[62]  E. Paykel,et al.  Expressed emotion and depression , 1997, British Journal of Psychiatry.

[63]  R. Prien,et al.  Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness. , 1973, Archives of general psychiatry.

[64]  P W Lavori,et al.  Relapse in major depressive disorder: analysis with the life table. , 1982, Archives of general psychiatry.

[65]  M. Tohen,et al.  Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. , 1991, Archives of general psychiatry.

[66]  G. Klerman,et al.  Long-term outcome of episodes of major depression. Clinical and public health significance. , 1984, JAMA.

[67]  K. Hawton,et al.  Do Psychosocial Factors Influence Outcome in Severely Depressed Female Psychiatric In-patients? , 1993, British Journal of Psychiatry.

[68]  S. Hollon,et al.  Depressed outpatients treated with cognitive therapy or pharmacotherapy. A one-year follow-up. , 1981, Archives of general psychiatry.

[69]  J. Davidson,et al.  Use of phenelzine in continuation therapy. , 1984, Neuropsychobiology.

[70]  F. Rouillon,et al.  Rechutes de dépression unipolaire et efficacité de la maprotiline , 1989 .

[71]  E. Paykel,et al.  Life events, social support and marital relationships in the outcome of severe depression , 1996, Psychological Medicine.

[72]  E. Smeraldi,et al.  Dose-response efficacy of paroxetine in preventing depressive recurrences: a randomized, double-blind study. , 1998, The Journal of clinical psychiatry.

[73]  G. Fava,et al.  Cognitive behavioral treatment of residual symptoms in primary major depressive disorder. , 1994, The American journal of psychiatry.

[74]  J. Endicott,et al.  Outcome of patients with chronic affective disorder: a five-year follow-up. , 1990, The American journal of psychiatry.

[75]  W. Coryell,et al.  Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. , 1999, The American journal of psychiatry.

[76]  A. D. Lunn,et al.  How Long Should the Elderly Take Antidepressants? , 1993, British Journal of Psychiatry.

[77]  I. Glick,et al.  Effectiveness in Psychiatric Care: A Cross-National Study of the Process of Treatment and Outcomes of Major Depressive Disorder , 1991, The Journal of nervous and mental disease.

[78]  C. Nemeroff,et al.  Correlation between the dexamethasone suppression test in depressed patients and clinical response. , 1984, The American journal of psychiatry.

[79]  D. Kupfer,et al.  Five-year outcome for maintenance therapies in recurrent depression. , 1990, Archives of general psychiatry.

[80]  I. Blackburn,et al.  A two-year naturalistic follow-up of depressed patients treated with cognitive therapy, pharmacotherapy and a combination of both. , 1986, Journal of affective disorders.

[81]  T. Crow,et al.  Combination tricyclic antidepressant and lithium maintenance medication in unipolar and bipolar depressed patients. , 1990, Journal of affective disorders.

[82]  D. Robinson,et al.  Continuation and maintenance treatment of major depression with the monoamine oxidase inhibitor phenelzine: a double-blind placebo-controlled discontinuation study. , 1991, Psychopharmacology bulletin.

[83]  M. Tohen,et al.  Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar disorders. , 1993, Archives of general psychiatry.

[84]  E. Paykel,et al.  Effects of maintenance amitriptyline and psychotherapy on symptoms of depression , 1975, Psychological Medicine.